Search

everythinglearnresearchcommunity

for

Search:↓

Ovarian hyperthecosis should be considered in young women with severe male-like symptoms and can be managed with hormone treatments.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Hirsutism, excessive male-pattern hair in women, can be caused by high androgens or skin sensitivity, diagnosed by testosterone levels, and treated with hair removal and hormone therapy.

Testosterone therapy in transgender individuals can increase the risk of erythrocytosis.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Treat hirsutism in premenopausal women with oral contraceptives and consider additional treatments if needed.

Certain enzymes react strongly with some hormones in rat skin during hair growth, mainly in sebaceous glands and hair sheaths.

A postmenopausal woman had high testosterone from her right adrenal gland, leading to recommended surgery.

Cyproterone acetate with estradiol improved women's self-confidence and emotional well-being without a difference between oral or transdermal methods, but younger women preferred the oral method.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

The document describes a treatment for excessive hair growth in a teenage girl using medication and birth control, but does not report the results.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

New compounds may soon be tested to treat excessive hair growth in women.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Long-pulsed ruby laser effectively reduces hair in male-to-female transsexuals.

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Patients with the same genetic mutation for vitamin D-resistant rickets showed different symptoms but all improved with treatment except for hair loss.

Hair loss and excessive growth treated with various options, including new laser technology.

Low estrogen and high testosterone may cause excessive hair growth in women.

Hydroxypinacolone retinoate is a potent anti-aging ingredient for skin that is more effective and less irritating than other forms of retinoids.

Using GnRHa agonists helps diagnose and treat ovarian hyperthecosis when surgery isn't possible.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

Parental support and gender-affirming care are crucial for the mental health of transgender adolescents.